Business Description
PharmX Technologies Ltd
NAICS : 511210
ISIN : AU0000298762
Description
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 23.84 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.13 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.17 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.8 | |||||
| 3-Year EBITDA Growth Rate | -12.6 | |||||
| 3-Year Book Growth Rate | -10.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.63 | |||||
| 9-Day RSI | 49.25 | |||||
| 14-Day RSI | 51.44 | |||||
| 3-1 Month Momentum % | 10.29 | |||||
| 6-1 Month Momentum % | 63.04 | |||||
| 12-1 Month Momentum % | 141.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.35 | |||||
| Quick Ratio | 5.35 | |||||
| Cash Ratio | 4.23 | |||||
| Days Sales Outstanding | 79.89 | |||||
| Days Payable | 283.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -0.11 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.53 | |||||
| Operating Margin % | -32.84 | |||||
| Net Margin % | 1.69 | |||||
| FCF Margin % | -129.51 | |||||
| ROE % | 0.74 | |||||
| ROA % | 0.46 | |||||
| ROIC % | -1.11 | |||||
| 3-Year ROIIC % | 3.78 | |||||
| ROC (Joel Greenblatt) % | 63.77 | |||||
| ROCE % | 1.19 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| PS Ratio | 6.67 | |||||
| PB Ratio | 2.96 | |||||
| Price-to-Tangible-Book | 8 | |||||
| EV-to-EBIT | 201.86 | |||||
| EV-to-EBITDA | 28.72 | |||||
| EV-to-Revenue | 6.06 | |||||
| EV-to-FCF | -4.81 | |||||
| Price-to-GF-Value | 4 | |||||
| Price-to-Projected-FCF | 4 | |||||
| Price-to-Median-PS-Value | 4 | |||||
| Price-to-Net-Current-Asset-Value | 8 | |||||
| Earnings Yield (Greenblatt) % | 0.49 | |||||
| FCF Yield % | -19.43 | |||||
| Forward Rate of Return (Yacktman) % | -19.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PharmX Technologies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 7.001 | ||
| EPS (TTM) (A$) | -0.003 | ||
| Beta | 1.37 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.54 | ||
| Volatility % | 80.42 | ||
| 14-Day RSI | 51.44 | ||
| 14-Day ATR (A$) | 0.002527 | ||
| 20-Day SMA (A$) | 0.08045 | ||
| 12-1 Month Momentum % | 141.94 | ||
| 52-Week Range (A$) | 0.026 - 0.085 | ||
| Shares Outstanding (Mil) | 598.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PharmX Technologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PharmX Technologies Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PharmX Technologies Ltd Frequently Asked Questions
What is PharmX Technologies Ltd(ASX:PHX)'s stock price today?
The current price of ASX:PHX is A$0.08. The 52 week high of ASX:PHX is A$0.09 and 52 week low is A$0.03.
When is next earnings date of PharmX Technologies Ltd(ASX:PHX)?
The next earnings date of PharmX Technologies Ltd(ASX:PHX) is .
Does PharmX Technologies Ltd(ASX:PHX) pay dividends? If so, how much?
PharmX Technologies Ltd(ASX:PHX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers